Coherent Market Insights Pvt Ltd

Life Sciences BPO Market to reach US$ 505 Billion by 2024 : Coherent Market Insights

Press Release   •   Jan 24, 2017 03:02 EST

The Global Life Sciences BPO Market was valued US$ 180.4 billion in 2015 and is projected to reach US$ 505.0 billion by 2024, according to a new report published by Coherent Market Insights. Reducing cost and increasing focus on core strengths is influencing medical device and pharmaceutical companies to outsource their processes to contract manufacturing organizations (CMO) and contract research organizations (CRO).

Get Free PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/24

Increasing demand for low cost drugs, rising cost pressure from various governments, patent cliffs, and uncertain regulatory conditions are factors contributing to increasing revenue growth of the global life sciences BPO market. Globally, pharmaceutical, and medical device companies are entering into strategic agreements with contract research organizations to leverage their expertise. This is helping them introduce new products at reduced costs and in turn obtain a competitive advantage.

In the current market scenario, outsourcing service is extended to medical coding, medical transcription, and clinical services. CMO and CROs provide products and services at much lower costs. Moreover, their regional regulatory expertise helps pharmaceutical and medical device companies to meet regulatory requirements in various countries.

Demand for life sciences BPO is high in Asia and Latin America due to large patient pool, easy availability of patients for clinical studies at a lower cost, and cost effective CMOs and CRO services. However, rising concerns over U.S. Food and Drug Administration (FDA) inspections in these regions is adversely impacting market growth to a certain extent. CMOs and CROs such as Divis Laboratories Ltd., Accenture pl., and PAREXEL International Corporation are investing to cater to demand for Good Manufacturing Practices (GMP) requirements and regain the trust and share for CMO and CRO market.

To know the latest trends and insights of this market, click the link below:

http://www.coherentmarketinsights.com/market-insight/life-sciences-bpo-market-24

Key takeaways of the market:

  • Constant endeavor for achieving high-quality results at low cost is driving demand for outsourcing in the global healthcare industry. This trend is expected to propel the global life science BPO market at a compound annual growth rate (CAGR) of 12.2% during the forecast period.
  • Pharmaceuticals outsourcing segment led the global life sciences BPO market with an estimated value of US$ 119.6 billion in 2015. Larger number of players are involved in contract manufacturing of pharmaceuticals and biotech products as compared to that of medical devices. In terms of medical devices, a contract manufacturer turns out to be the long-term manufacturer for that particular device. Pharmaceutical companies on the other hand, have cost-based contracts with CMO, as shifting to other vendors (CMOs) is easy due to presence of large number of contract manufacturers worldwide.
  • In terms of end users, healthcare providers dominate the market and accounted for a share of 89.1% in 2015. Healthcare providers which include manufacturers, and research organizations are using these services in order to streamline their process, and focus on core business.
  • Currently, market players such as Accenture plc. Cognizant Technology Solutions, Catalent, Inc., Covance, Inc., Boehringer Ingelheim GmbH and Genpact Limited are offering a plethora of service as a one-stop solution to healthcare providers to outsource their processes.

Request For Customization: https://www.coherentmarketinsights.com/insight/request-customization/24

ABOUT US

COMPANY OVERVIEW

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.